We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+2.53%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$842M
AUM Growth
+$160M
(+23%)
Cap. Flow
+$179M
Cap. Flow
% of AUM
21.25%
Top 10 Holdings %
Top 10 Hldgs %
32.27%
Holding
254
New
89
Increased
38
Reduced
24
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$12.6M |
| 2 |
Wells Fargo
WFC
|
+$12.2M |
| 3 |
Huntington Bancshares
HBAN
|
+$11.7M |
| 4 |
Exelon
EXC
|
+$11.1M |
| 5 |
Peabody Energy
BTU
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Denali Therapeutics
DNLI
|
+$12.4M |
| 2 |
Truist Financial
TFC
|
+$8.47M |
| 3 |
Progressive
PGR
|
+$8.43M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$8.1M |
| 5 |
Cboe Global Markets
CBOE
|
+$6.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.59% |
| 2 | Technology | 20.4% |
| 3 | Healthcare | 19.9% |
| 4 | Utilities | 11.57% |
| 5 | Industrials | 11.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Gold Fields
GFI
$29B
| $2M | 0.24% |
+150,000
| New | +$1.67M |
|
|
ALE
102
DELISTED
Allete
ALE
| $1.96M | 0.23% |
+30,500
| New | +$1.91M |
|
103
Eversource Energy
ES
$26.9B
| $1.96M | 0.23% |
+25,000
| New | +$1.97M |
|
104
Equifax
EFX
$20.3B
| $1.92M | 0.23% |
+9,479
| New | +$1.97M |
|
105
Silicon Motion
SIMO
$8.6B
| $1.85M | 0.22% |
28,290
-4,781
| -14% | -$314K |
|
106
KKR & Co
KKR
$91.1B
| $1.84M | 0.22% |
+35,000
| New | +$1.88M |
|
107
Morgan Stanley
MS
$331B
| $1.76M | 0.21% |
+20,000
| New | +$1.87M |
|
108
Avery Dennison
AVY
$13B
| $1.62M | 0.19% |
+9,056
| New | +$1.65M |
|
109
Portland General Electric
POR
$5.71B
| $1.59M | 0.19% |
+32,500
| New | +$1.55M |
|
110
Q2 Holdings
QTWO
$3.8B
| $1.58M | 0.19% |
+64,240
| New | +$1.91M |
|
111
EXL Service
EXLS
$5.14B
| $1.49M | 0.18% |
+46,105
| New | +$1.53M |
|
|
GTM
112
ZoomInfo Technologies
GTM
$973M
| $1.49M | 0.18% |
+60,301
| New | +$1.55M |
|
113
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
| $1.35M | 0.16% |
+40,000
| New | +$1.36M |
|
114
Travere Therapeutics
TVTX
$5.2B
| $1.35M | 0.16% |
+60,000
| New | +$1.28M |
|
115
CME Group
CME
$96.3B
| $1.34M | 0.16% |
7,000
-33,000
| -83% | -$5.97M |
|
116
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.37B
| $1.26M | 0.15% |
26,000
-90,000
| -78% | -$4.33M |
|
117
Old National Bancorp
ONB
$10.2B
| $1.25M | 0.15% |
+86,891
| New | +$1.47M |
|
118
Pegasystems
PEGA
$5.02B
| $1.25M | 0.15% |
51,618
+22,406
| +77% | +$472K |
|
|
119
Truist Financial
TFC
$63.3B
| $1.19M | 0.14% |
35,000
-194,000
| -85% | -$8.47M |
|
120
Okta
OKTA
$24.7B
| $1.16M | 0.14% |
+13,471
| New | +$1.03M |
|
121
Datadog
DDOG
$95.4B
| $1.15M | 0.14% |
15,830
+1,796
| +13% | +$132K |
|
122
Principal Financial Group
PFG
$24.3B
| $1.11M | 0.13% |
+15,000
| New | +$1.27M |
|
123
Celldex Therapeutics
CLDX
$2.99B
| $1.09M | 0.13% |
30,262
-6,103
| -17% | -$263K |
|
124
Procore
PCOR
$8.26B
| $1.05M | 0.12% |
+16,740
| New | +$979K |
|
|
GDNR
125
DELISTED
Gardiner Healthcare Acquisitions Corp. Common Stock
GDNR
| $1.05M | 0.12% |
+100,000
| New | +$1.04M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2023 Portfolio in Review
As of Q1 2023, Crestline Management held 254 positions worth $842M, up 23% from $682M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Crestline Management deployed $179M of net new capital in Q1 2023, opening 89 new positions and adding to 38 existing holdings. Its largest new stake was TSMC: 140,000 shares worth $13M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Denali Therapeutics, an estimated $12.4M trimmed.
- Crestline Management's largest Q1 2023 buy was TSMC: 140,000 shares worth $13M.
- Crestline Management added most to Wells Fargo in Q1 2023, an estimated $12.2M increase.
- Crestline Management's biggest Q1 2023 reduction was Denali Therapeutics, cutting an estimated $12.4M.
- Crestline Management fully exited Progressive in Q1 2023, selling an estimated $8.43M.
- Crestline Management's ten largest holdings make up 32% of its $842M portfolio in Q1 2023.
- Crestline Management opened 89 new positions and closed 97 in Q1 2023.
- Crestline Management's portfolio value rose 23% quarter-over-quarter to $842M.
Based on Crestline Management's 13F filing for Q1 2023, filed 15 May 2023.